Orphazyme receives offers, begins negotiations with potential buyer

Embattled biotech firm Orphazyme has announced on Friday it has received ”certain non-binding offers,” entailing the full purchase of all of the company’s assets and operations, from several undisclosed parties. (Updated)
Photo: Nikolaj Skydsgaard/Reuters/Ritzau Scanpix
Photo: Nikolaj Skydsgaard/Reuters/Ritzau Scanpix
by albert rønning-andersson, translated by daniel pedersen

Biotech firm Orphazyme might be taken under someone else’s wing.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading